Go Deep
XBiotech Inc.
XBiotech Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 22,077 | -1.5 | 0.51 | 0.00 | 205.09 |
| Oct 2026 | 22,077 | -1.5 | 0.51 | 0.00 | 205.12 |
| Oct 2026 | 22,140 | -1.4 | 0.50 | 0.00 | 200.80 |
| Oct 2026 | 22,329 | -1.4 | 0.47 | 0.00 | 189.63 |
| Oct 2026 | 22,298 | -1.4 | 0.48 | 0.00 | 191.53 |
| Oct 2026 | 22,345 | -1.3 | 0.47 | 0.00 | 188.22 |
| Oct 2026 | 22,376 | -1.3 | 0.47 | 0.00 | 185.95 |
| Oct 2026 | 22,439 | -1.3 | 0.46 | 0.00 | 182.93 |
XBiotech Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Profit | -6,728,000.0 | -5,505,000.0 | -26,892,000.0 | -6,008,000.0 |
| EPS | -0.2 | -0.2 | — | -0.2 |
XBiotech Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 4,010,000.0 | — |
| Net Profit | -45,540,000.0 | -38,531,000.0 | -24,557,000.0 | -32,900,000.0 | — |
| EPS | -1.5 | -1.3 | -0.8 | -1.1 | — |
XBiotech Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 150,082,000.0 | 199,093,000.0 | 226,615,000.0 | 246,103,000.0 | — |
| Total Liabilities | 9,732,000.0 | 16,825,000.0 | 7,769,000.0 | 5,701,000.0 | — |
| Total Equity | 140,350,000.0 | 182,268,000.0 | 218,846,000.0 | 240,402,000.0 | — |
Owes vs Owns
XBiotech Inc. owed $0.04 for every $1 it owned in Jun 2026, up from $0.02 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.04× | 0.06× | 0.08× | 0.03× | 0.02× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
XBiotech Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 83.7%Fixed assets (tangible) 15.4%Other assets 0.7%
How it's funded — Dec 2025
Payables 1.0%Other liabilities 5.5%Shareholders' equity 93.5%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 125.6 | 172.7 | 200.0 | 217.5 |
| Receivables | 0.4 | 0.9 | 0.9 | 1.8 |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 |
| Fixed assets (tangible) | 23.1 | 24.5 | 24.9 | 26.3 |
| Intangible assets | 0.0 | 0.0 | 0.0 | 0.0 |
| Long-term investments | 0.0 | 0.0 | 0.0 | 0.0 |
| Other assets | 1.0 | 1.0 | 0.8 | 0.6 |
| Liabilities & equity | ||||
| Short-term debt | 0.0 | 10.2 | 0.0 | 0.0 |
| Long-term debt | 0.0 | 0.0 | 0.0 | 0.0 |
| Payables | 1.5 | 2.2 | 2.5 | 2.4 |
| Other liabilities | 8.2 | 4.4 | 5.3 | 3.3 |
| Shareholders' equity | 140.3 | 182.3 | 218.8 | 240.4 |
| Net tangible assets | 140.3 | 182.3 | 218.8 | 240.4 |
XBiotech Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | -39,920,000.0 | -30,963,000.0 | -18,725,000.0 | -14,824,000.0 | — |
| Investing Activities | -289,000.0 | -1,304,000.0 | 61,497,000.0 | -63,892,000.0 | — |
| Financing Activities | -10,250,000.0 | 10,450,000.0 | -9,000.0 | 0.0 | — |